Literature DB >> 33149331

Opioid-Related Education Provided by Continuing Education Divisions at US Pharmacy Schools.

Mandy L Renfro1, Leticia R Moczygemba1, Jennifer Baumgartner2, Glen Baumgart1, Lucas G Hill1.   

Abstract

Objective. To quantify the number and type of new opioid-related continuing pharmacy education (CPE) activities offered by continuing education divisions (CEDs) at US schools and colleges of pharmacy from 2015 through 2018, and to determine the number of pharmacists who completed opioid-related CPE activities. Methods. Data was derived from the database of CPE activities maintained by the Accreditation Council for Pharmacy Education (ACPE), which is the sole accreditation agency for all providers of CPE, including pharmacy schools. Data were filtered to include only pharmacy school CPE providers. A search for six keywords (opiates, opioids, pain, pain management, drug overdose, and opioid antagonist) was conducted for the years 2015-2018. The data extracted included title of the CPE activity, contact hours, activity type, activity format, and the number of pharmacists who participated in the activity. Descriptive statistics were used. A content analysis of activity titles was performed. Results. Overall, the CEDs of US schools and colleges of pharmacy delivered 20.3% of all ACPE-approved opioid-related CPE activities from 2015-2018. A total of 1,237 unique opioid-related CPE activities were identified. The number of new CPE activities increased from 249 in 2015 to 297 in 2016 to 349 in 2017, then decreased to 342 in 2018. These activities reached 149,373 pharmacists and were most commonly affiliated with the following keywords: opioids (34.8%) and pain management (30.2%). Conclusion. The opioid epidemic creates an opportunity for pharmacists to increase their role in public health, but education and training are necessary. The study findings indicate that many pharmacists participate in opioid-related CPE provided by ACPE-accredited CEDs of pharmacy schools. This number is likely to increase as a growing number of states are beginning to require opioid-related CPE for pharmacist license renewal.
© 2020 American Association of Colleges of Pharmacy.

Entities:  

Keywords:  continuing pharmacy education; naloxone; opioids

Mesh:

Substances:

Year:  2020        PMID: 33149331      PMCID: PMC7596601          DOI: 10.5688/ajpe8001

Source DB:  PubMed          Journal:  Am J Pharm Educ        ISSN: 0002-9459            Impact factor:   2.047


  22 in total

1.  Assessing pharmacists' readiness to dispense naloxone and counsel on responding to opioid overdoses.

Authors:  Francis Melaragni; Carly Levy; Jennifer Pedrazzi; Merissa Andersen
Journal:  J Am Pharm Assoc (2003)       Date:  2019-05-17

2.  State naloxone access laws are associated with an increase in the number of naloxone prescriptions dispensed in retail pharmacies.

Authors:  Jing Xu; Corey S Davis; Marisa Cruz; Peter Lurie
Journal:  Drug Alcohol Depend       Date:  2018-05-29       Impact factor: 4.492

3.  Provision of Naloxone Without a Prescription by California Pharmacists 2 Years After Legislation Implementation.

Authors:  Talia Puzantian; James J Gasper
Journal:  JAMA       Date:  2018-11-13       Impact factor: 56.272

4.  The implementation of a naloxone rescue program in university students.

Authors:  Shannon G Panther; Brenda S Bray; John R White
Journal:  J Am Pharm Assoc (2003)       Date:  2017-01-04

5.  Pharmacists' role in opioid overdose: Kentucky pharmacists' willingness to participate in naloxone dispensing.

Authors:  Patricia R Freeman; Amie Goodin; SuZanne Troske; Audra Strahl; Amanda Fallin; Traci C Green
Journal:  J Am Pharm Assoc (2003)       Date:  2017-01-28

6.  Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration's national program.

Authors:  Elizabeth M Oliva; Melissa L D Christopher; Daina Wells; Mark Bounthavong; Michael Harvey; Julianne Himstreet; Thomas Emmendorfer; Michael Valentino; Mariano Franchi; Francine Goodman; Jodie A Trafton
Journal:  J Am Pharm Assoc (2003)       Date:  2017 Mar - Apr

Review 7.  Pharmacist involvement with immunizations: a decade of professional advancement.

Authors:  Michael D Hogue; John D Grabenstein; Stephan L Foster; Mitchel C Rothholz
Journal:  J Am Pharm Assoc (2003)       Date:  2006 Mar-Apr

8.  Association Between State Laws Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal Overdose.

Authors:  Rahi Abouk; Rosalie Liccardo Pacula; David Powell
Journal:  JAMA Intern Med       Date:  2019-06-01       Impact factor: 21.873

9.  Opioid-overdose laws association with opioid use and overdose mortality.

Authors:  Chandler McClellan; Barrot H Lambdin; Mir M Ali; Ryan Mutter; Corey S Davis; Eliza Wheeler; Michael Pemberton; Alex H Kral
Journal:  Addict Behav       Date:  2018-03-19       Impact factor: 3.913

10.  Predicting pharmacy naloxone stocking and dispensing following a statewide standing order, Indiana 2016.

Authors:  B E Meyerson; J D Agley; A Davis; W Jayawardene; A Hoss; D J Shannon; P T Ryder; K Ritchie; R Gassman
Journal:  Drug Alcohol Depend       Date:  2018-04-26       Impact factor: 4.492

View more
  1 in total

Review 1.  Considering the Potential Benefits of Over-the-Counter Naloxone.

Authors:  Kirk E Evoy; Lucas G Hill; Corey S Davis
Journal:  Integr Pharm Res Pract       Date:  2021-02-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.